Contract Opportunity Award Details General Information Classification Description Attachments/Links Contact Information History Award Notices Follow NOTICE OF INTENT TO SOLE SOURCE: Automated Flow Cytometry Assay Preparation System Active Contract Opportunity Notice ID 1333ND22PNB640548 Related Notice NB644020-22-02490 Contract Line Item Number Department/Ind.
The instrument will use fully automated liquid handling system to transfer antibodies and buffers which can minimize assay manual pipetting errors and inter-user variability. The automated Flow Cytometry Assay Preparation System is critical for reproducibility and productivity using flow cytometry assay when characterizing cells and quantitative measuring antibodies and cytokines in human or murine samples.
Requirement: NIST is seeking information from sources that provide: Automated Flow Cytometry Assay Preparation Systems Specific capabilities Automatic dispense, fix, stain, wash, and transfer samples. Touch screen interface. Customizable parameters such as flow rates and number of washes. Flexible reprogramming for different assay protocols. Washing cells without centrifugation. Washing 96 samples in less than 10 minutes.
This is for the reagents and consumables to perform routine flow cytometry assays on a VA owned FACSCanto II flow cytometer (SN: V96100771) with automated loader (SN: F06500621). The FACSCanto with automated loader currently owned by the VA is manufactured by BD Biosciences Immunocytometry Systems. BD Bioscience is the exclusive manufacturer and supplier of the BD FACSCanto, instrument, and reagents.
(End of Clause) STATEMENT OF WORK DEPARTMENT OF VETERANS AFFAIRS FLOW CYTOMETRY REAGENTS AND SERVICE DESCRIPTION: The Contractor shall provide all reagents and consumables for performing routine flow cytometry assays and maintenance service of a flow cytometer for The Department of Veterans Affairs Medical Center in Washington DC (VAMCDC), 50 Irving St. NW Washington DC 20422, for 1 base year and 4 option years.
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with GenScript USA Inc to procure synthetic peptides to continue analyzing the responses in on-going studies by various flow cytometry and immunological assays.
Specific techniques required include Enzyme Linked ImmunoSorbent Assays (ELISA), flow cytometry, Indirect Hemagglutination Assays (IHA), Luminex MagPix, and Rapid Diagnostic Tests (RDTs).- Diagnostic Tissue Culture: NAMRU-3 requires contractor support services to conduct tissue culture activities in support of viral pathogen detection and characterization.
-Immunology: NAMRU-3 requires contractor support services to conduct immunological assays on blood and serum collected from human and animal sources to test for evidence of exposure to pathogenic organisms of interest. Specific techniques required include Enzyme Linked ImmunoSorbent Assays (ELISA), flow cytometry, Indirect Hemagglutination Assays (IHA), Luminex MagPix, and Rapid Diagnostic Tests (RDTs).
COLI O157 CONFIRMATION TYPING E-TEST SUSCEPTIBILITIES FACTOR X ASSAY FLOW CYTOMETRY HEPARIN (QUANTITATIVE) HLA AB SCREEN HLA COMPLETE AG IMMUNOHISTOCHEMISTRY SPECIAL TISSUE STAINS MALARIA SMEAR ORGANISM ID ORGANISM ID MYCOLOGY PLATELET FUNCTION ANALYSIS QUANT DUODENAL ASPIRATE CULTURE RENAL PATHOLOGY EXAM & DIAGNOSIS SALMONELLA/SHIGELLA CONFIRMATION SUSCEPTIBILITIES TACROLIMUS THROMBIN CLOTTING TIME THYROGLOBULIN PANEL VARICELLA